Thyroid nodules withKRASmutations are different from nodules withNRASandHRASmutations with regard to cytopathologic and histopathologic outcome characteristics-Reference-Cited by-同舟云学术

Thyroid nodules withKRASmutations are different from nodules withNRASandHRASmutations with regard to cytopathologic and histopathologic outcome characteristics

Published:2014-08-12 Issue:12 Volume:122 Page:873-882
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Radkay Lisa A.¹,Chiosea Simion I.¹,Seethala Raja R.¹,Hodak Steven P.²,LeBeau Shane O.²,Yip Linwah³,McCoy Kelly L.³,Carty Sally E.³,Schoedel Karen E.¹,Nikiforova Marina N.¹,Nikiforov Yuri E.¹,Ohori N. Paul¹

Affiliation:

1. Department of Pathology; University of Pittsburgh Medical Center-Presbyterian; Pittsburgh Pennsylvania

2. Division of Endocrinology; University of Pittsburgh Medical Center-Presbyterian; Pittsburgh Pennsylvania

3. Division of Endocrine Surgery; University of Pittsburgh Medical Center-Presbyterian; Pittsburgh Pennsylvania

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. The Bethesda System for Reporting Thyroid Cytopathology

2. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations;Ohori;Acta Cytol,2011

3. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology;Cantara;J Clin Endocrinol Metab,2010